SGX Market Updates

21 Non-STI Stocks Attracting Significant Trading Activity in 2021 YTD


PUBLISHED ON |

12 April 2021

  • Singapore’s 21 most traded non-STI stocks in the 2021 year-to-date have traded S$220 million in turnover a day, 15% of the total turnover of all stocks and trusts listed on SGX. Key contributors to trading activity included stock capitalisation, previous earnings reports, and economic drivers, namely semiconductor demand and defensive COVID-19 traits.

  • The 21 stocks averaged 27% gains (13% median gains) on multiple outlier performances. Thomson Medical, iFAST Holdings & ISDN Holdings led the 21 stocks in the year-to-date. Thomson Medical reported y-o-y turnaround profit for its 1HFY21 (end 31 Dec), while for FY20 (end 31 Dec), iFAST reported more than 100% y-o-y net profit growth, and ISDN Holdings reported more than 100% y-o-y growth in profit attributable to shareholders.

  • The 5 of the 21 non-STI stocks recipient to the highest net institutional and Proprietary trading flows were Singapore Press Holdings (SPH), Sembcorp Marine, Thomson Medical, UMS Holdings and iFAST Corporation. With combined inflows of S$212 million, the 5 stocks averaged 8% gains over the first 6 sessions of April, bringing their 2021 year-to-date average total return to 71%.




The Straits Times Index (“STI”) has performed comparatively strongly in the 2021 year to 9 April, with a 12.5% total return, ranking the benchmark Asia Pacific’s second best performer over the first 14 weeks of the year, after the Taiwan Stock Exchange Weighted Index.

Meanwhile, Singapore’s 21 most traded stocks outside of the STI that span 8 Sectors, have on average kept pace with the benchmark, generating a median 12.5% total return, with the average total return at 27.3%. Together with 29 of the 30 STI stocks, these 21 stocks comprise Singapore’s 50 most traded stocks in the 2021 year to 9 April. All 21 non-STI stocks saw more trading turnover than the least traded STI stock over the period.


Stock SGX
Code
Market
Cap
S$m
YTD
Trading
Turnover
Ranking
April MTD
Total Return
%
YTD
Net Insti &
Net Prop Flow
S$M
YTD
Total
Return
%
Sector
AEM Holdings AWX 1,149 18 -1 -29.9 19 Technology (Hardware/ Software)
Singapore Press Holdings T39 2,801 22 15 83.9 56 Cyclicals
Sembcorp Marine S51 2,511 24 18 56.8 40 Industrials
Frasers Logistics & Commercial Trust BUOU 5,040 26 1 -20.1 4 REITs
Suntec REIT T82U 4,569 30 3 7.2 10 REITs
Keppel REIT K71U 4,469 32 0 18.9 13 REITs
Jiutian Chemical C8R 183 33 11 0.7 12 Materials & Resources
Oceanus ^* 579 1,045 34 10 -17.9 59 Non-Cyclicals
UMS Holdings 558 741 36 5 23.1 29 Technology (Hardware/ Software)
iFAST Corporation AIY 1,728 37 2 19.7 109 Technology (Hardware/ Software)
NetLink NBN Trust CJLU 3,741 38 2 -51.5 -0.5 Telecommunications
Nanofilm Technologies MZH 3,394 39 3 -15.7 17 Technology (Hardware/ Software)
Top Glove BVA 13,607 40 12 -68.3 -11 Healthcare
Frasers Centrepoint Trust J69U 4,246 41 2 -4.9 2 REITs
ISDN Holdings I07 287 44 9 -1.0 63 Industrials
Medtecs International 546 538 45 6 -0.1 -2 Healthcare
CapitaLand China Trust AU8U 2,116 46 1 4.6 0.4 REITs
Thomson Medical A50 2,961 47 0 28.4 124 Healthcare
Mapletree North Asia Commercial Trust RW0U 3,709 48 2 -2.7 11 REITs
Sheng Siong OV8 2,315 49 0 -79.1 -0.6 Non-Cyclicals
Riverstone Holdings AP4 1,971 50 8 -0.3 20 Healthcare
Average 5.1 27.3
Median 2.6 12.5

^* Note SGX has told Oceanus that it will have to meet the Financial Watchlist Exit Criteria by 15 April 2021 or be delisted. If it is delisted, the company is to provide an exit offer that is fair and reasonable.
Sourced by SGX, Refinitiv & Bloomberg (Data as of 9 April 2021).



There were multiple contributors to the trading activity across these 21 stocks over the past 14 weeks.


Multiple stocks logically attract a high level of turnover as they maintain a comparative high level of market capitalisation.

All 5 stocks of the STI Reserve List are among the 21 stocks -

  • Frasers Logistic & Commercial Trust,
  • Suntec REIT,
  • Keppel REIT,
  • Frasers Centrepoint Trust and
  • NetLink NBN Trust.

Frasers Logistic & Commercial Trust is scheduled to join the STI effective tomorrow, with Jardine Strategic deleted from the Index, assuming the Jardine Matheson Holdings' proposal to acquire the 15% of Jardine Strategic Holdings share capital that it does not already own is approved during tonight’s Special General Meeting.

Unlike Jardine Matheson, which has added exposure to Jardine Motors and Jardine Pacific, Jardine Strategic's revenue exposures are all replicable through the other public listings of the group.

Frasers Logistic & Commercial Trust’s portfolio comprises 100 properties that span industrial and commercial real estates, a portfolio value of approximately $6.2 billion, with the properties diversified across five developed countries - Australia, Germany, Singapore, the United Kingdom and the Netherlands. However, the key reason Frasers Logistic & Commercial Trust is joining the STI is because of its market capitalisation of S$5 billion, which is attributed to the merger of Frasers Logistics and Industrial Trust and Frasers Commercial Trust which was completed a year ago in April 2020.


Thomson Medical Group led the 21 stocks in 2021 to 9 April stock performance, and reported 1HFY20 (ended 31 Dec) profit growth back in February. The next two best performers among the 21 stocks over the past 14 weeks, iFAST Corporation and ISDN Holdings, also reported FY20 (ended 31 Dec) profit growth, back in February and March.

On 8 February, Thomson Medical Group reported the Group’s Adjusted EBITDA recorded a 32.6% increase to S$31.8 million, compared to S$24.0 million in the same period last year, attributed to grants received via support schemes and initiatives from the Singapore government to help employers through the COVID-19 pandemic. In addition to lower interest rates and the absence of the real property gain tax rate in Malaysia, Thomson Medical Group recorded a net profit after tax of S$9.7 million for its 1HFY21 (ended 31 Dec), compared to a loss of S$1.0 million in the same period last year (excluding COVID-19 related grants from the Singapore government, the Group remained profitable recording a net profit after tax of S$4.5 million), click here for more.

On 5 February, iFAST Corporation reported its FY20 (ended 31 Dec) net profit grew 122.3% y-o-y to S$21.15 million, on the back of 31.7% y-o-y increase in net revenue and 35.5% y-o-y growth in gross revenue, click here for more.

On 1 March, ISDN Holdings reported its Group revenue for FY20 (ended 31 Dec) surged by 24.4% y-o-y to S$361.9 million, with robust demand across all geographies. As a result of growth in both sales and productivity, profit attributable to shareholders rose by 114.8% to S$15.1 million for FY20, click here for more.


Economic drivers have included demand for semiconductors in addition to some rotation to medical suppliers in early January and April.

This week will provide much insight into the pace and trajectory of the economic rebound in Singapore. On Wednesday both the Monetary Authority of Singapore (“MAS”) will release its semi-annual Monetary Policy Statement, at the same time Singapore’s advance GDP estimates for 1Q21 which are expected to see the a narrower y-o-y loss, in addition to a slower sequential, q-o-q gain. GDP has been recently supported by manufacturing growth which has now registered four consecutive months of month-on-month gains. Demand for semiconductors in 1Q21 has seen AEM Holdings generate a 19.1% gain in the 2021 year to 9 April, while UMS Holdings has added 28.7% and Nanofilm Technologies has gained 16.6%.

There were no surprises in the FOMC meetings last week that the path of US economy would depend significantly on the course of the virus, including progress on vaccinations. While the IMF did provide an upward revision to 2021 global growth estimates, it maintained much still depends on the race between the virus and vaccines. This is where markets have turned more cautious in early April. Top Glove Corporation, Medtecs International and Riverstone Holdings, which rank among the 21 most traded non-STI stocks averaged 8.6% gains over the first 6 sessions of April.

Topline statistics show that as of 11 April, there have been 774 million vaccinations administered around the globe, as compared to 136 million confirmed cases. However, since Mid-March, daily global cases have been gradually reversing that downtrend observed over the first six weeks of 2021.

  • On 8 April, new confirmed cases reached more than 100 cases per 1 million people, returning to levels seen in early January, and more than doubled the less than 40 cases per 1 million people observed on 8 March.
  • On 11 April new confirmed cases fell back to 67 cases per 1 million people.

As the International Monetary Fund inferred we can see the finish line, however as US President Biden remarked last week, the world is not at the finish line yet.







This article is provided by SGX My Gateway.



SGX My Gateway

SGX's investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.

This document is not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the SGX Group Companies) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.












Stock / REIT Search

Advertisement

Advertisement